BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 20217609)

  • 1. Colloidal gold: a novel nanoparticle for targeted cancer therapeutics.
    Powell AC; Paciotti GF; Libutti SK
    Methods Mol Biol; 2010; 624():375-84. PubMed ID: 20217609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LHRH-targeted nanoparticles for cancer therapeutics.
    Minko T; Patil ML; Zhang M; Khandare JJ; Saad M; Chandna P; Taratula O
    Methods Mol Biol; 2010; 624():281-94. PubMed ID: 20217603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of nanoparticles for targeted, noninvasive thermal destruction of malignant cells.
    Cherukuri P; Curley SA
    Methods Mol Biol; 2010; 624():359-73. PubMed ID: 20217608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular-targeted therapy for cancer and nanotechnology.
    Hochwald SN
    Methods Mol Biol; 2010; 624():11-23. PubMed ID: 20217586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of nanotechnology in biomedicine.
    Navalakhe RM; Nandedkar TD
    Indian J Exp Biol; 2007 Feb; 45(2):160-5. PubMed ID: 17375555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic aerosol targeting of nanoparticles to cancer: nanomagnetosols.
    Rudolph C; Gleich B; Flemmer AW
    Methods Mol Biol; 2010; 624():267-80. PubMed ID: 20217602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of timing, dose and interstitial versus nanoparticle delivery of tumor necrosis factor alpha in combinatorial adjuvant cryosurgery treatment of ELT-3 uterine fibroid tumor.
    Jiang J; Bischof J
    Cryo Letters; 2010; 31(1):50-62. PubMed ID: 20309509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle enhanced thermal therapies.
    Shenoi MM; Anderson J; Bischof JC
    Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():1979-82. PubMed ID: 19964027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle therapeutics: FDA approval, clinical trials, regulatory pathways, and case study.
    Eifler AC; Thaxton CS
    Methods Mol Biol; 2011; 726():325-38. PubMed ID: 21424459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
    Fadeel B; Garcia-Bennett AE
    Adv Drug Deliv Rev; 2010 Mar; 62(3):362-74. PubMed ID: 19900497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-assembling nanoclusters in living systems: application for integrated photothermal nanodiagnostics and nanotherapy.
    Zharov VP; Kim JW; Curiel DT; Everts M
    Nanomedicine; 2005 Dec; 1(4):326-45. PubMed ID: 17292107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of nanoparticles: folate receptor.
    Kularatne SA; Low PS
    Methods Mol Biol; 2010; 624():249-65. PubMed ID: 20217601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.
    Muthu MS; Singh S
    Nanomedicine (Lond); 2009 Jan; 4(1):105-18. PubMed ID: 19093899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nanomedicine: chance or risk for the patients?].
    Kathmann W
    Dtsch Med Wochenschr; 2009 May; 134(19):p19. PubMed ID: 19424944
    [No Abstract]   [Full Text] [Related]  

  • 15. Nanomedicine: magnetic nanoparticles hit the target.
    Amirfazli A
    Nat Nanotechnol; 2007 Aug; 2(8):467-8. PubMed ID: 18654342
    [No Abstract]   [Full Text] [Related]  

  • 16. Thermal scalpel to target cancer.
    Everts M
    Expert Rev Med Devices; 2007 Mar; 4(2):131-6. PubMed ID: 17359220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticles for thermal cancer therapy.
    Day ES; Morton JG; West JL
    J Biomech Eng; 2009 Jul; 131(7):074001. PubMed ID: 19640133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric nanoparticles for drug delivery.
    Chan JM; Valencia PM; Zhang L; Langer R; Farokhzad OC
    Methods Mol Biol; 2010; 624():163-75. PubMed ID: 20217595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha.
    Halin C; Gafner V; Villani ME; Borsi L; Berndt A; Kosmehl H; Zardi L; Neri D
    Cancer Res; 2003 Jun; 63(12):3202-10. PubMed ID: 12810649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine: novel approaches in human and veterinary therapeutics.
    Irache JM; Esparza I; Gamazo C; Agüeros M; Espuelas S
    Vet Parasitol; 2011 Aug; 180(1-2):47-71. PubMed ID: 21680101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.